“The closure of the Gaza Strip puts at risk the health of people in Gaza and undermines the functioning of the health care system."
Today, one year after Israel’s military offensive on Gaza, UN Agencies and the Association for International Development Agencies (AIDA), representing over 80 NGOs, are highlighting the impact of the blockade on Gaza on the health of Gaza’s population and on health services - and are calling for an immediate opening of Gaza’s crossings.
Max Gaylard, the Resident Humanitarian Coordinator for the oPt, said on Wednesday 20th January 2010 “The continuing closure of the Gaza Strip is undermining the functioning of the health care system and putting at risk the health of 1.4 million people in Gaza. It is causing on-going deterioration in the social, economic and environmental determinants of health. It is hampering the provision of medical supplies and the training of health staff and it is preventing patients with serious medical conditions getting timely specialised treatment outside Gaza”.
The economy of Gaza is in virtual collapse with rising unemployment and poverty which will have long term adverse effects on the physical and mental health of the population. The environment is also in decline including water quality, sewage and waste disposal and other environmental hazards (including munitions and medical waste) which may lead to long term effects on health.
More than 750,000 children live in Gaza. The humanitarian community is gravely concerned about the future of this generation whose health needs are not being met. The decline in infant mortality, which has occurred steadily over recent decades, has stalled in the last few years.
The lack of building materials as a result of the blockade is affecting essential health facilities: the new surgical wing in Gaza’s main Shifa hospital has remained unfinished since 2006. Hospitals and primary care facilities, damaged during operation ‘Cast Lead’, have not been rebuilt because construction materials are not allowed into Gaza. Operation ‘Cast Lead’ damaged 15 of Gaza’s 27 hospitals and 43 of its 110 primary health care facilities were either damaged or destroyed.
Supplies of drugs and disposables have generally been allowed into Gaza – though there are often shortages on the ground. However, certain types of medical equipment, such as x-ray equipment and electronic devices are very difficult to bring in. Clinical staff frequently lack the medical equipment they need. Medical devices are often broken, missing spare parts or out of date.
Health professionals in Gaza have been cut off from the outside world. Since 2000, very few doctors, nurses or technicians have been able to leave the Strip for training necessary to update their clinical skills or to learn about new medical technology. This is severely undermining their ability to provide quality health care.
Many specialised treatments, for example, complex heart surgery and certain types of cancer, are not available in Gaza and patients are therefore referred for treatment to hospitals outside Gaza. But many patients have had the applications for exit permits denied or delayed by the Israeli Authorities and have missed their appointments. Some have died while waiting for referral.
Tony Laurance, the Head of Office for WHO West Bank and Gaza, said that “An effective health care system cannot be sustained in isolation from the international community. Open borders are needed to ensure the health of the1.4 million people in Gaza”.
The humanitarian community believes the health sector would face serious problems in dealing with another emergency on the scale of last year’s Operation Cast Lead. The Government of Israel has a legal duty to guarantee the right to health for people in Gaza. The humanitarian community calls for the crossings into Gaza to be reopened.
Media Contacts:
Chiara Stefanini- Advocacy and Human Rights Officer, WHO
Cell: 972 (0)54 717 9024 Email:
Mike Bargman
Cell: 050-680-9255 Email:
Richard Miron-Chief Public Information Officer, UNSCO
Mobile: +972 (0)54 562 7825 Email:
Vaccination Week in the Eastern Mediterranean Regions
With a spirit of integration, commitment and cooperation, health authorities from countries across the Region are in the final stage of preparations for the first Vaccination Week in the Eastern Mediterranean. This initiative, led by the World Health Organization (WHO) Regional Office for the Eastern Mediterranean will take place from 24 to 30 April 2010 and coincides with similar endeavours established in two other WHO regions ─ Vaccination Week in the Americas and European Immunization Week.
Vaccination Week in the Eastern Mediterranean provides a unique opportunity to revive the Region’s commitment and increase public awareness on the importance of immunization through advocacy, education and communication. To date, the initiative has received overwhelming support, with participation from the 22 countries of the Eastern Mediterranean Region. A variety of activities will be carried out during the week including outreach, campaigns, workshops, training sessions, social mobilization, round tables, exhibitions and media events addressing a wide range of vaccine-related issues. The target audiences for these activities include parents, caregivers, health workers, mass media, decision-makers and stakeholders.
Under the patronage of Her Excellency Mrs Wafaa Michel Sleiman, First Lady of Lebanon, the regional launching ceremony of the Vaccination Week will be held in Beirut on Saturday, 24 April 2010. As a respected public figure advocating for the well-being of people in the Region, H.E the First Lady will bring much-deserved attention to the vital role of immunization in preventing illness and death from vaccine-preventable diseases. Her genuine interest and commitment to public health will help attract key decision-makers and stakeholders in the Region to the message that an immunized and healthy child will have a better chance at education and development.
Vaccines and immunization have played a remarkable and important role in protecting an increasing number of people against vaccine-preventable diseases. With support from the Regional Office, countries in the Region have witnessed remarkable success in reducing morbidity and mortality. Some regional achievements include: the eradication of smallpox; increased vaccination coverage with three doses of diphtheria–tetanus–pertussis (DTP3) vaccine from 18% in 1980 to 87% in 2009; reaching the 90% measles mortality reduction target three years ahead of schedule; maintaining 20 polio-free countries; and utilizing national immunization programmes as a platform to provide other life-saving health interventions such as vitamin A supplements, bed nets to prevent malaria and de-worming medicine.
Despite substantial progress in immunizing more people over the past two decades, the Region continues to face major challenges. Every day, more than 5500 infants are not fully immunized and an estimated 2.1 million children did not receive DTP3 vaccine in 2009. Moreover, a large number of child deaths due to penumococcal disease and rotavirus diarrhoea can be prevented through vaccination with newly available vaccines. But introducing these vaccines into national immunization programmes will require additional financial commitment from countries and donors. Other regional challenges include eradicating polio from Afghanistan and Pakistan, and eliminating measles and maternal and neonatal tetanus.
For more information on Vaccination Week, visit www.emro.who.int/vpi/vwem or contact:
Diagnosis and Treatment of Tuberculosis Patients in the Eastern Mediterranean Region.
Since the year 2000, 2 343 900 people with tuberculosis (TB) in the WHO Eastern Mediterranean Region have successfully been provided with treatment and care through DOTS, the basic package that underpins the global Stop TB strategy. However, millions more people in countries of the Region still do not have access to quality tuberculosis care.
Before World TB Day, 24 March, and at the launch of its report Multidrug and extensively drug-resistant tuberculosis: 2010 global report on surveillance and response, WHO has warned of the rise in number of cases of drug-resistant tuberculosis and has called for an urgent scaling up of efforts to control tuberculosis, including its severe forms.
According to the latest estimates, the tuberculosis case detection rate, i.e. the number of new tuberculosis patients registered, is still low in the Eastern Mediterranean Region, at 58%. In contrast, the global target for case detection is 70%, as set by the Global Plan to Stop TB (2006–2015) in order to achieve the relevant targets of the Millennium Development Goals. It is estimated that 90% of the undetected tuberculosis patients are in Afghanistan, Pakistan, Somalia and Sudan. However, this does not suggest that tuberculosis is not a problem in other countries of the Region. Limited awareness of this preventable and curable disease, inadequate infrastructure to detect, diagnose and treat patients and limited involvement of health care providers outside the national tuberculosis programme are common challenges to many countries of the Region.
To meet the challenges in expanding quality tuberculosis care and access and scaling up efforts against the drug-resistant forms, especially in countries with high disease burden, innovation is urgently needed at each level of regional response. Engaging community, media, health care providers, academic and financial institutions through partnership is needed now more than ever.
On World TB Day 2009, the Million Youth March mobilized more than 1.8 million young people and tuberculosis workers, supporters and advocates to march and reiterate their solidarity with and support for 1 million tuberculosis patients in the Region. For World Health Day 2010, innovation in tuberculosis care is being celebrated by countries through music and activities involving former tuberculosis patients, youth and health workers, who are at the forefront of the fight against tuberculosis.
Dr Hussein A. Gezairy, WHO Regional Director for Eastern Mediterranean, in his message on TB Day, emphasized the need to take up the struggle with renewed spirit and hope. He said “World TB Day, held every year on 24 March, exists to remind us that we should not let this situation continue. The Day is not just to remember tuberculosis. It is also to renew our commitment and efforts. Getting everyone together, pooling our resources and putting up a joint fight that can be sustained are the purpose of the Day”.